Basket | Login | Register

 
 
 
 

Cyprus

Reimbursement of anti-dementia drugs

The availability of medicines in general

In Cyprus, medicines are provided by hospitals or institutions. Drugs prescribed are included in an approved list. Patients are required to pay 50% of the costs of treatments on the approved list. [1]

The availability of Alzheimer treatments

All anti-dementia drugs are available in Cyprus and are part of the reimbursement system. Alzheimer Europe was unable to obtain detailed information on reimbursement restrictions in Cyprus.

 

Donepezil

Rivastigmine

Galantamine

Memantine

Reimbursement

Yes

Yes

Yes

Yes

Initial treatment decision

No information

No information

No information

No information

Continuing treatment decision

No information

No information

No information

No information

Required examinations

No information

No information

No information

No information

MMSE limits

No information

No information

No information

No information

People living alone

No information

No information

No information

No information

People in nursing homes

No information

No information

No information

No information

[1] European Commission (2006): MISSOC – Mutual information system on social protection : Social protection in the Member States of the European Union, of the European Economic Area and in Switzerland : Comparative tables

 

 
 

Last Updated: mercredi 15 juillet 2009

 

 
 

Options

  • Send this page to a friend